Clinical trial
PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
NCT00004152 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004152 |
|---|---|
| Title | PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma |
| Official title | A Pilot Study to Compare 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) Scanning in Addition to CT Scanning With CT Scanning Alone in the Pre-Operative Evaluation of Patients With Stage III and IV Melanoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | iodinated contrast dye, computed tomography, positron emission tomography, fludeoxyglucose F 18 |
| Start date | Feb 1, 1999 |
| Primary completion | Dec 1, 2002 |
| First posted | Feb 16, 2004 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: